GHRP-6

Human Research

Growth Hormone Releasing Peptide-6

An early growth hormone releasing peptide known for its powerful appetite stimulation and GH release. One of the most studied GHRPs in research literature.

SubQ injectionGrowth HormoneBody Composition

Dose

100-300 mcg

Route

SubQ injection

Cycle

8-12 weeks

Storage

2-8°C (refrigerator) for up to 2 years, or -20°C (freezer) for longer term

What is GHRP-6?

GHRP-6 is one of the earliest and most extensively studied Growth Hormone Releasing Peptides. It acts as a potent ghrelin mimetic, binding to the ghrelin/growth hormone secretagogue receptor (GHSR-1a) in the pituitary and hypothalamus. This interaction leads to a significant pulsatile release of growth hormone (GH) from the anterior pituitary. A hallmark effect of GHRP-6 commonly observed in research is its powerful appetite-stimulating property, mediated through its agonism of ghrelin receptors. It does not contain an opioid peptide sequence, despite initial structural similarities to met-enkephalin. Research explores its potential roles in various physiological processes, particularly those related to growth, metabolism, and appetite regulation.

Key Benefits

Strong GH release
Extreme appetite stimulation
IGF-1 increase
Body composition support

Mechanism of Action

Ghrelin receptor agonist
Stimulates GH release
Strong appetite stimulation via ghrelin pathways

Best For

GH research
Hard gainers / appetite research
Body composition

Body Systems

EndocrineMusculoskeletalGastrointestinal

🐾 Griffin Says...

GHRP-6 is famous for the hunger. We are talking ravenous. If that's a research variable you want to control, choose ipamorelin instead. But if appetite stimulation is part of the research goal, GHRP-6 delivers it reliably.

Molecular Information

Molecular weight

873.0 g/mol

Length

6 amino acids

Type

Peptide

Amino acid sequence

His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

H-His-D-Trp-Ala-Trp-D-Phe-Lys-NH2

Pharmacokinetics

Time to peak

15-30 minutes

Half-life

0.25 h

Time to clear

Approximately 2 hours

DoseEstimated plasma concentration2 h

Based on studies in humans and animals, showing rapid clearance.

Research Indications

Stimulation of Endogenous GH Release
GHRP-6 is a potent secretagogue, directly stimulating the pituitary gland to release growth hormone.
Pulsatile GH Release Pattern
Research indicates it promotes a more natural pulsatile release of GH compared to exogenous GH administration.

Research Protocols

Goal	Dose	Frequency	Route
General GH Release and Appetite Stimulation	100 mcg	3 times daily	Subcutaneous injection
Enhanced GH Release for Body Composition	200-300 mcg	2-3 times daily	Subcutaneous injection
Maximizing Pulsatile GH Peak	100-200 mcg	Prior to breakfast, prior to dinner, and before bed	Subcutaneous injection
Researching Effects on Appetite	100 mcg	30-60 minutes before meals	Subcutaneous injection
Combination with GHRH Analog (e.g., CJC-1295)	50-100 mcg GHRP-6	2-3 times daily (co-administered with GHRH)	Subcutaneous injection

To maximize pulsatile GH release and minimize potential blunting from elevated IGF-1 or blood glucose, administration on an empty stomach is commonly discussed.

Peptide Interactions

GHRH Analogs (e.g., CJC-1295, Sermorelin)
Co-administration with GHRH analogs is commonly discussed in research for significantly amplified GH release, as they act via different mechanisms to stimulate GH.
Synergistic
Insulin
GHRP-6 can increase GH, which may have anti-insulin effects. Monitor blood glucose, especially in subjects with insulin sensitivity issues.
Use Caution
Somatostatin
GHRP-6 can overcome somatostatin-induced inhibition of GH release, making it effective even in its presence.
Compatible
Glucose/Food Intake
Administration on a full stomach or with high blood glucose can blunt the GH-releasing effect of GHRP-6. Best administered on an empty stomach.
Monitor Combination
Corticosteroids
Corticosteroids can reduce GH secretion and may counteract some of the intended effects of GHRP-6. Careful monitoring is advised.
Monitor Combination
Growth Hormone (Exogenous)
Co-administration may lead to supraphysiological GH levels. Research protocols typically focus on stimulating endogenous GH rather than combining with exogenous forms.
Monitor Combination

How to Reconstitute

1Gather GHRP-6 vial, bacteriostatic water (BW), and sterile syringe.
2Remove plastic cap from GHRP-6 vial and clean rubber stopper with an alcohol wipe.
3Draw desired amount of BW into the syringe (e.g., 1 ml for 5mg vial to achieve 5mg/ml concentration).
4Slowly inject BW into the GHRP-6 vial, directing the stream down the side of the glass, not directly onto the lyophilized powder.
5Do not shake the vial. Gently swirl or roll the vial between palms to dissolve the powder completely. This may take a few minutes.
6Once fully dissolved, store the reconstituted solution in the refrigerator.

Always reconstitute with bacteriostatic water for injection (BW) to maintain sterility and prolong shelf life.

What to Expect

Week 1-2: Noticeable increase in appetite is a common immediate effect. Some individuals report improved sleep.
Week 3-4: Potential for subtle improvements in recovery and energy levels may begin to be observed.
Week 5-8: More pronounced effects on body composition, such as minor reductions in body fat and slight increases in lean mass, may become apparent in conjunction with appropriate lifestyle.
Week 9-12: Peak benefits in terms of body composition and overall well-being are often reported in this phase of a research cycle.
Post-cycle: Appetite stimulation will cease rapidly after discontinuation. Long-term effects on body composition require sustained healthy lifestyle practices.

Side Effects & Safety

Effect	Frequency	Severity
Extreme hunger	Very Common	Mild
Water retention	Common	Mild
Cortisol increase	Common	Mild

Ready to calculate your dose? Use Griffin's Peptide Calculator 🐾

Open Calculator

Peptides discussed here are for research purposes only. Nothing on this page is medical advice. Always consult a qualified professional before making health decisions.